Author

Cathleen Park

Institutions: University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center

Observed institutions: University of California, Irvine, Cancer Consortium, UC Irvine Chao Family Comprehensive Cancer Center, UC Davis Comprehensive Cancer Center, University of Cincinnati, University of California, Davis, University of Cincinnati Medical Center

OpenAlex ID: A5028729062

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

2021 · Michael A. Thompson, Jeffrey P. Henderson, et al. · JAMA Oncology · 192

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

2022 · Julie Fu, Sonya A. Reid, et al. · JAMA Network Open · 66

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

2020 · Maheen Abidi, David M. Aboulafia, et al. · Cancer Cell · 31

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

2022 · Jessica E. Hawley, Tianyi Sun, et al. · JAMA Network Open · 10

Tissue and plasma-based mechanisms of resistance to first-line osimertinib in EGFR-mutant NSCLC: A multi-institutional cohort.

2023 · Zofia Piotrowska, Lanyi Nora Chen, et al. · Journal of Clinical Oncology · 9

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

2022 · Michael J. Wagner, Cassandra Hennessy, et al. · Cancers · 5

A phase 2 basket trial of tarlatamab in patients with advanced DLL3-expressing tumors: University of California Lung Cancer Consortium UCCC-01/UCLA L-10.

2025 · Michael Oh, Daniel P. Stefanko, et al. · Journal of Clinical Oncology · 1

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

2021 · Michael J Wagner, Matthew Ingham, et al. · Journal of Clinical Oncology · 1

MET Tyrosine Kinase Domain Mutations in NSCLC: Expanding the Landscape of Acquired Resistance in Oncogene-Driven Tumors

2025 · Zhaohui Liao Arter, Cathleen Park, et al. · Journal of Thoracic Oncology

Phase I study evaluating the safety and preliminary anti-tumor efficacy of receptor mediated bispecific nano-immunoengager in advanced solid tumors

2023 · Jonathan Riess, Kit Lam, et al. · International Journal of Cancer Care and Delivery

Real world early experience of precision neoadjuvant systemic therapy in patients with resectable NSCLC: Single institution experiences and perspectives.

2023 · Cathleen Park, Kyra Toomey, et al. · Journal of Clinical Oncology

Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.

2021 · Dimpy P Shah, Pankil Shah, et al. · Journal of Clinical Oncology

Works count: 12

Citation count: 315

H-index: 5

I10-index: 4